84 related articles for article (PubMed ID: 1492842)
21. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans].
Hlavica P; Niebch G
Arzneimittelforschung; 1985; 35(1):67-74. PubMed ID: 4039154
[TBL] [Abstract][Full Text] [Related]
23. Excretion and metabolism of flunarizine in rats and dogs.
Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
[TBL] [Abstract][Full Text] [Related]
24. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
Obermeier K; Niebch G; Thiemer K
Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
[TBL] [Abstract][Full Text] [Related]
26. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of amlodipine. Identification and synthesis of metabolites found in rat, dog and human urine/confirmation of structures by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
Beresford AP; Macrae PV; Alker D; Kobylecki RJ
Arzneimittelforschung; 1989 Feb; 39(2):201-9. PubMed ID: 2525041
[TBL] [Abstract][Full Text] [Related]
28. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
[TBL] [Abstract][Full Text] [Related]
30. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
31. In vivo metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in rats and dogs: pharmacokinetics, isolation, identification, and quantification of metabolites.
Takenaga N; Ishii M; Nakajima S; Hasegawa T; Iwasa R; Ishizaki H; Kamei T
Drug Metab Dispos; 1999 Feb; 27(2):205-12. PubMed ID: 9929504
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
Okuyama Y; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic properties of antileukemic and trypanocidal compounds with amidino and imidazolinyl groups.
Gluth WP; Busch U
Arzneimittelforschung; 1984; 34(11):1542-51. PubMed ID: 6543129
[TBL] [Abstract][Full Text] [Related]
34. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
35. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
Chen IW; Lin JH
Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
[TBL] [Abstract][Full Text] [Related]
36. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
Waldmeier F; Glaenzel U; Wirz B; Oberer L; Schmid D; Seiberling M; Valencia J; Riviere GJ; End P; Vaidyanathan S
Drug Metab Dispos; 2007 Aug; 35(8):1418-28. PubMed ID: 17510248
[TBL] [Abstract][Full Text] [Related]
37. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites.
Weber W; Michaelis K; Luckow V; Kuntze U; Stalleicken D
Arzneimittelforschung; 1995 Jul; 45(7):781-4. PubMed ID: 8573222
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
